Endoscopic Accessories Market Size, Share, Growth, and Industry Analysis, By Type (Biopsy Forceps, Grasping Forceps, Injection Needle, Polypectomy Snare, Clip Fixing Devices, Coagulation Devices, ESD and EMR Devices, Hemoclip Handle, Others), By Application (Laparoscopy, GI Endoscopy, Arthroscopy, Urology Endoscopy, Bronchoscopy), Regional Insights and Forecast to 2035
Endoscopic Accessories Market Overview
Global Endoscopic Accessories Market size is projected to reach USD 3744.45 Million by 2035, rising from USD 2095.78 Million in 2026 at a CAGR of 6.66%.
| Metric | Value |
|---|---|
| Largest Region | North America (35%) |
| Largest Application | GI Endoscopy (49%) |
| Largest Product Type | Biopsy Forceps (20%) |
| Major Market Trend | Advanced endoscopic resection and precision accessories (11%) |
| Leading Companies | Olympus Corporation (19%) and Fujifilm Holdings Corporation (14%) |
The Endoscopic Accessories Market is expanding as healthcare providers increasingly adopt minimally invasive diagnostic and therapeutic procedures across gastroenterology, surgery, pulmonology, and urology. GI Endoscopy represents a modeled 49% of application demand, supported by extensive utilization of tissue sampling instruments, polypectomy snares, injection needles, and hemostasis accessories. These instruments assist physicians in collecting specimens, removing selected lesions, controlling bleeding, and performing targeted interventions through endoscopic working channels. Manufacturers are developing improved device flexibility, reliable deployment mechanisms, and ergonomic handling characteristics. Demand is supported by colorectal cancer screening, gastrointestinal disease management, and growing availability of therapeutic endoscopy. Hospitals increasingly prioritize instruments compatible with advanced visualization platforms and established infection prevention procedures. Product innovation also emphasizes precise tissue interaction and dependable procedural performance. Continued investment in specialized endoscopy services supports demand for diagnostic and therapeutic accessories.
The United States Endoscopic Accessories Market benefits from established endoscopy centers, advanced hospital infrastructure, and demand for minimally invasive treatment technologies. North America represents a modeled 35% of the global market, supported by colorectal cancer screening programs, specialty clinical services, and established medical device distribution networks. Companies including Olympus Corporation, Fujifilm Holdings Corporation, Stryker, Conmed, and other manufacturers participate through endoscopy systems and associated procedural technologies. American healthcare providers increasingly require dependable biopsy instruments, resection accessories, and endoscopic bleeding-control devices. Hospitals are also evaluating single-use technologies where appropriate to support infection prevention and operational efficiency. Regulatory requirements emphasize device safety, performance validation, and suitable instructions for use. Continued investment in advanced therapeutic endoscopy strengthens domestic demand for specialized accessories.
Key Findings
- Market Driver: Increasing demand for minimally invasive gastrointestinal diagnosis and treatment supports accessory consumption, with GI Endoscopy representing a modeled 49% of application demand across tissue sampling, polyp removal, and bleeding-control procedures.
- Major Market Restraint: Device sterilization requirements, procurement costs, and compatibility limitations influence adoption, while Biopsy Forceps account for a modeled 20% product share and require dependable manufacturing quality and appropriate infection-control practices.
- Emerging Trends: Advanced therapeutic endoscopy is expanding demand for specialized resection instruments, with ESD and EMR Devices representing a modeled 11% product share across increasingly sophisticated gastrointestinal treatment procedures.
- Regional Leadership: North America leads the Endoscopic Accessories Market with a modeled 35% share, supported by established healthcare infrastructure, colorectal screening activity, therapeutic endoscopy services, and advanced medical equipment adoption.
- Competitive Landscape: Olympus Corporation holds a modeled 19% competitive share, supported by its established endoscopy platforms, EndoTherapy portfolio, clinical relationships, and continuing development of advanced diagnostic and therapeutic instruments.
- Market Segmentation: Biopsy Forceps lead the supplied product categories with a modeled 20% share, while GI Endoscopy remains the largest application through widespread demand for tissue sampling and endoscopic treatment.
- Recent Development: Olympus expanded its endoscopic technology portfolio in August 2026 with a global respiratory cryobiopsy distribution agreement, supporting Bronchoscopy, which represents a modeled 8% application share.
Latest Trends
The Endoscopic Accessories Market is witnessing increasing adoption of specialized devices supporting complex gastrointestinal interventions. ESD and EMR Devices account for a modeled 11% of product demand, reflecting interest in minimally invasive resection of selected mucosal and submucosal lesions. Endoscopic submucosal dissection and endoscopic mucosal resection require suitable cutting, injection, traction, and hemostasis accessories. Manufacturers are developing advanced instruments that improve maneuverability, precise tissue interaction, and procedural control. Modern endoscopy systems increasingly combine high-resolution imaging with specialized therapeutic channels to support demanding interventions.
Single-use accessories and infection prevention technologies represent another significant industry trend. Biopsy Forceps account for a modeled 20% of the supplied product distribution, highlighting the importance of reliable tissue sampling instruments. Healthcare facilities increasingly evaluate disposable devices for selected applications where reprocessing complexity or contamination risk influences procurement decisions. Single-use products can eliminate the need to reprocess the individual accessory, although associated waste management and procurement costs require consideration.
Market Dynamics
Driver
"Increasing diagnostic and therapeutic endoscopy procedures strengthen accessory demand."
The growing need for gastrointestinal disease diagnosis and treatment represents a major driver for the Endoscopic Accessories Market. GI Endoscopy contributes a modeled 49% of application demand, reflecting extensive utilization of tissue sampling and therapeutic instruments. Colorectal cancer screening, gastrointestinal bleeding management, and evaluation of digestive disorders require appropriately selected endoscopic accessories. Biopsy forceps collect tissue specimens, while snares and other instruments support removal of selected lesions.
Expansion of minimally invasive surgical techniques provides another important growth driver. Laparoscopy represents a modeled 19% of supplied application demand, supported by widespread adoption of procedures performed through small surgical access points. Surgeons require appropriate grasping, coagulation, and tissue-handling instruments to conduct minimally invasive interventions. Healthcare providers increasingly prioritize procedural precision and suitable visualization systems.
Restraint
"Device reprocessing requirements and procedural expenses limit broader adoption."
Infection prevention and instrument reprocessing requirements represent significant restraints within the Endoscopic Accessories Market. Biopsy Forceps account for a modeled 20% product share, emphasizing substantial demand for instruments used in tissue sampling procedures. Reusable accessories must undergo appropriate cleaning, inspection, and validated reprocessing according to their intended use. Improper procedures can increase contamination risks and compromise patient safety.
Equipment compatibility and specialized operating requirements create additional restraints. ESD and EMR Devices represent a modeled 11% of product demand, reflecting their use in technically demanding procedures. Therapeutic accessories must fit the working channels of compatible endoscopes and provide appropriate mechanical or electrical performance. Advanced procedures require trained clinicians and reliable supporting equipment. Healthcare facilities may face difficulties introducing new instruments when existing systems lack required capabilities.
Opportunity
"Advanced therapeutic instruments and expanding healthcare services create new opportunities."
Development of precision accessories for therapeutic endoscopy represents a significant market opportunity. Polypectomy Snare products account for a modeled 17% of supplied product demand, supported by their use in removing selected gastrointestinal polyps. Manufacturers increasingly develop instruments with improved loop control, reliable deployment, and suitable compatibility with electrosurgical equipment where applicable. Different clinical situations require accessories with appropriate sizes, configurations, and mechanical characteristics.
Expansion of specialized respiratory endoscopy creates additional opportunities for accessory manufacturers. Bronchoscopy contributes a modeled 8% of application demand, supported by diagnostic sampling and selected therapeutic procedures involving the airways. Olympus announced a global distribution agreement in August 2026 for a respiratory cryobiopsy system, demonstrating continued development of specialized bronchoscopic instruments.
Challenge
"Maintaining procedural reliability and device compatibility challenges manufacturers."
Achieving consistent procedural performance remains a significant challenge across endoscopic accessory categories. Clip Fixing Devices account for a modeled 13% of product demand, reflecting their importance in selected endoscopic hemostasis and tissue closure procedures. Manufacturers must ensure reliable opening, positioning, and deployment under appropriate clinical conditions. Differences in anatomy and endoscope positioning can influence device handling. Clinicians require clear visualization and predictable mechanical performance when placing accessories.
Managing safety requirements and complex product development processes creates another important industry challenge. Coagulation Devices represent a modeled 9% of supplied product demand, requiring appropriate electrical performance and careful interaction with surrounding tissue. Manufacturers must evaluate energy delivery characteristics, insulation integrity, and compatibility with supporting equipment. Clinical users require suitable training to minimize unintended tissue injury. Regulatory processes also demand documentation demonstrating device safety and performance.
Segmentation
By Types
Biopsy Forceps: Biopsy Forceps lead the supplied product segmentation with a modeled 20% market share, supported by widespread use in endoscopic tissue sampling. These instruments allow clinicians to obtain specimens from selected areas for pathological examination. Manufacturers develop different jaw configurations, shaft dimensions, and handling mechanisms to suit procedural requirements. Product selection depends on tissue characteristics, endoscope compatibility, and clinical objectives. Healthcare facilities emphasize dependable sample acquisition and appropriate infection-control procedures. Continued demand for accurate diagnostic evaluation supports this category.
Grasping Forceps: Grasping Forceps represent a modeled 12% market share, supported by demand for controlled tissue manipulation and selected foreign-body retrieval procedures. Manufacturers develop different tip configurations and flexible shaft structures to support handling requirements. Clinicians require dependable gripping performance and compatibility with appropriate endoscopes. Instruments must provide suitable mechanical control without unnecessary tissue trauma. Specialized designs support different diagnostic and therapeutic applications. Continued development of minimally invasive treatment technologies strengthens demand for grasping accessories.
Injection Needle: Injection Needle accounts for a modeled 10% market share, reflecting its importance in selected gastrointestinal therapeutic interventions. Endoscopic injection needles can deliver suitable solutions into targeted tissue layers during authorized clinical procedures. Manufacturers emphasize needle extension control, flexibility, and dependable fluid delivery. Appropriate product selection depends on procedural technique and endoscope specifications. Single-use designs support standardized handling practices where suitable. Continued growth in therapeutic endoscopy creates opportunities for advanced injection devices.
Polypectomy Snare: Polypectomy Snare contributes a modeled 17% market share, supported by widespread use during endoscopic polyp removal. These accessories incorporate flexible loop designs selected according to lesion characteristics and treatment requirements. Manufacturers develop products suitable for cold or electrosurgical techniques as clinically appropriate. Reliable opening, closure, and device handling influence procedural performance. Gastrointestinal screening programs support recurring demand for compatible snare technologies. Continued improvements in resection techniques strengthen this segment.
Clip Fixing Devices: Clip Fixing Devices account for a modeled 13% market share, supported by selected procedures requiring hemostasis or tissue closure. Manufacturers develop controlled clip deployment mechanisms designed for use through compatible endoscopic channels. Clinicians require reliable positioning and predictable release characteristics. Product innovation emphasizes precise handling and appropriate mechanical retention. Different clip designs address distinct procedural requirements. Continued expansion of therapeutic endoscopy supports demand for specialized closure accessories.
Coagulation Devices: Coagulation Devices represent a modeled 9% market share, reflecting demand for endoscopic instruments supporting selected tissue treatment and bleeding-control procedures. These devices require appropriate energy delivery and compatibility with supporting systems. Manufacturers prioritize electrical safety, instrument handling, and consistent performance. Clinicians select equipment according to procedural requirements and relevant clinical guidance. Product development emphasizes precise control and reliable construction. Continued adoption of therapeutic endoscopy supports this segment.
ESD and EMR Devices: ESD and EMR Devices account for a modeled 11% market share, supported by increasing use of advanced endoscopic resection techniques. These accessories assist selected procedures involving mucosal or submucosal lesion removal. Manufacturers develop specialized cutting, dissection, and tissue-management instruments to support procedural precision. Clinical use requires suitable expertise and equipment compatibility. Advanced visualization and controlled accessory movement contribute to effective treatment. Continued development of minimally invasive gastrointestinal interventions supports demand.
Hemoclip Handle: Hemoclip Handle represents a modeled 4% market share, reflecting demand for reliable control mechanisms used with compatible hemostatic clip systems. These devices support precise clip handling during selected endoscopic procedures. Manufacturers emphasize ergonomic design and dependable mechanical operation. Clinicians require suitable compatibility and predictable deployment performance. Appropriate product maintenance and handling procedures remain important. Continued development of specialized hemostasis technologies supports this product category.
Others: Others contributes a modeled 4% market share, covering additional endoscopic accessories outside the principal supplied categories. Demand arises from specialized diagnostic and therapeutic procedures requiring compatible support instruments. Manufacturers develop application-specific features based on clinical requirements and device design constraints. Product development emphasizes reliability, maneuverability, and suitable sterilization or single-use arrangements. Specialist healthcare facilities require dependable technical documentation and training. Continued innovation supports opportunities for specialized endoscopic products.
By Applications
Laparoscopy: Laparoscopy represents a modeled 19% application share, supported by increasing utilization of minimally invasive surgical techniques. Surgeons require instruments suitable for grasping, coagulation, and tissue management during procedures performed through small incisions. Accessory selection depends on the surgical technique, equipment compatibility, and clinical requirements. Manufacturers develop ergonomic and reliable instruments designed for controlled manipulation. Hospitals emphasize appropriate sterilization and procedural efficiency. Continued development of minimally invasive surgery strengthens demand for compatible accessories.
GI Endoscopy: GI Endoscopy leads the supplied application categories with a modeled 49% market share, reflecting extensive use of diagnostic and therapeutic accessories. Gastrointestinal procedures require biopsy forceps, snares, injection needles, clipping systems, and specialized treatment devices. Colorectal screening and digestive disease management create recurring demand. Manufacturers increasingly develop accessories compatible with modern endoscopy platforms. Healthcare providers prioritize clinical effectiveness, dependable handling, and appropriate infection prevention. Continued expansion of therapeutic endoscopy supports this application.
Arthroscopy: Arthroscopy accounts for a modeled 12% application share, supported by minimally invasive diagnosis and treatment of selected joint disorders. Surgeons require specialized instruments compatible with arthroscopic visualization and access systems. Manufacturers emphasize durability, controlled handling, and procedural precision. Healthcare facilities increasingly evaluate instruments designed to support efficient operating room workflows. Product selection depends on anatomical requirements and surgical techniques. Continued advances in minimally invasive orthopedic procedures support demand.
Urology Endoscopy: Urology Endoscopy represents a modeled 12% application share, supported by diagnostic and therapeutic procedures involving the urinary tract. Clinicians use compatible accessories for tissue sampling, manipulation, and selected treatments. Manufacturers develop instruments suited to narrow access pathways and specialized endoscopic equipment. Product reliability and appropriate infection-control procedures remain essential. Healthcare providers increasingly prioritize minimally invasive urological treatment options. Continued development of specialized endoscopy technology supports demand.
Bronchoscopy: Bronchoscopy contributes a modeled 8% application share, reflecting demand for diagnostic airway sampling and selected therapeutic interventions. Pulmonologists require instruments compatible with flexible bronchoscopes and relevant clinical techniques. Advanced biopsy technologies support tissue acquisition in appropriate cases. Manufacturers emphasize suitable flexibility, deployment control, and patient safety. Healthcare facilities require appropriate training and validated equipment compatibility. Continued investment in respiratory diagnostic services supports this application category.
Regional Outlook
North America
North America leads the Endoscopic Accessories Market with a modeled 35% share, supported by established healthcare infrastructure and extensive gastrointestinal screening activity. The United States contributes through advanced hospital facilities, specialized endoscopy centers, and medical device innovation. Healthcare providers increasingly adopt minimally invasive diagnostic and therapeutic techniques. Manufacturers maintain established distribution networks and clinical training capabilities. Hospitals emphasize device performance, infection prevention, and appropriate regulatory compliance. Continued investment in advanced gastrointestinal care supports regional market demand and accessory development.
Europe
Europe represents a modeled 26% market share, supported by established healthcare services and widespread utilization of minimally invasive procedures. Germany, France, the United Kingdom, and other European countries contribute through specialist clinical services and medical technology development. Manufacturers including Karl Storz and Hoya Group maintain important connections with regional healthcare systems. Hospitals increasingly evaluate advanced endoscopic resection and hemostasis technologies. Regulatory requirements emphasize device safety and quality management. Continued investment in modern clinical infrastructure supports regional market development.
Asia-Pacific
Asia-Pacific accounts for a modeled 29% market share, supported by growing healthcare infrastructure and increasing utilization of advanced endoscopy technologies. Japan, China, India, and South Korea contribute through specialist medical services and expanding hospital capabilities. Companies including Olympus Corporation and Fujifilm Holdings Corporation maintain significant regional technology expertise. Gastrointestinal screening and minimally invasive treatment create demand for diagnostic and therapeutic accessories. Manufacturers increasingly develop training partnerships and distribution arrangements. Continued healthcare modernization strengthens regional market opportunities.
Middle East and Africa
Middle East and Africa represents a modeled 6% market share, supported by expanding specialist healthcare services and investment in modern medical facilities. Regional hospitals increasingly introduce minimally invasive diagnostic and therapeutic technologies. Endoscopic accessories support gastrointestinal, respiratory, and urological procedures where suitably trained personnel are available. International manufacturers contribute through medical equipment partnerships and distribution networks. Clinical training and equipment availability influence adoption. Continued healthcare infrastructure development supports gradual regional expansion.
Rest of the World
Rest of the World accounts for a modeled 4% market share, including Latin American and smaller developing healthcare markets. Demand is supported by expanding hospital capacity and increasing access to specialized endoscopic procedures. Healthcare providers require dependable accessories suited to available equipment and clinical capabilities. International suppliers support regional product availability through distributors and training partnerships. Procurement conditions and reimbursement arrangements influence technology adoption. Continued investment in healthcare infrastructure creates additional market opportunities.
List of Top Endoscopic Accessories Companies
- Olympus Corporation
- Fujifilm Holdings Corporation
- Stryker
- Hoya Group
- Karl Storz
- Medovations
- Endo-Technik
- EndoChoice Holdings
- US Endoscopy
- Conmed
- Solos Endoscopy
- Medivators
- Medorah Meditek
Top Two Companies with Highest Market Share
- Olympus Corporation: Modeled 19% competitive share, supported by its extensive endoscopic accessory portfolio, established therapeutic instrument technologies, international distribution capabilities, and ongoing investment in advanced gastrointestinal procedures.
- Fujifilm Holdings Corporation: Modeled 14% competitive share, supported by its advanced endoscopy platforms, specialized therapeutic accessories, clinical technology development, and expanding presence in gastrointestinal treatment applications.
Investment Analysis and Opportunities
Investment opportunities in the Endoscopic Accessories Market increasingly emphasize therapeutic innovation, manufacturing reliability, and specialized clinical technologies. GI Endoscopy accounts for a modeled 49% of application demand, highlighting extensive requirements for instruments supporting diagnosis and treatment. Manufacturers are investing in advanced snare designs, precision biopsy devices, hemostasis technologies, and compatible endoscopic accessories.
Expansion of minimally invasive procedures creates additional opportunities for manufacturers developing adaptable endoscopic instruments. Laparoscopy represents a modeled 19% of application demand, supported by growing utilization of specialized surgical techniques. Healthcare providers increasingly invest in advanced visualization and compatible treatment technologies. Manufacturers developing instruments with reliable handling characteristics and appropriate safety features may strengthen relationships with hospitals.
New Product Development
New product development in the Endoscopic Accessories Market increasingly emphasizes precision tissue handling, advanced hemostasis technologies, and specialized therapeutic instruments. Bronchoscopy represents a modeled 8% of application demand, supported by continued development of advanced airway sampling technologies. Olympus announced a global distribution agreement in August 2026 for a respiratory cryobiopsy system designed to support selected bronchoscopic procedures.
Gastrointestinal therapeutic technologies are also advancing through improved endoscope maneuverability and accessory compatibility. ESD and EMR Devices represent a modeled 11% of product demand, reflecting requirements for advanced tissue resection instruments. Fujifilm expanded its therapeutic endoscopy portfolio during August 2026 with next-generation gastroscopes featuring advanced imaging and dedicated therapeutic capabilities. Manufacturers are developing compatible accessories supporting precise injection, tissue dissection, and hemostasis procedures.
Five Recent Developments
| Date | Company | Development |
|---|---|---|
| March 2026 | Olympus Corporation | Olympus introduced its next-generation VISERA ELITE III surgical imaging platform in the United States. The technology supports improved visualization during minimally invasive procedures and provides a platform for compatible surgical instruments. |
| May 2026 | Olympus Corporation | Olympus announced a global distribution agreement with EndoRobotics, adding robot-assisted technologies to its EndoTherapy portfolio. The partnership supports advanced gastrointestinal intervention and specialized instrument development. |
| August 2026 | Olympus Corporation | Olympus announced a global distribution agreement with Endocision for a portable single-use flexible cryocatheter system. The arrangement expands its respiratory sampling technology portfolio for selected bronchoscopic applications. |
| August 2026 | Fujifilm Holdings Corporation | Fujifilm India launched advanced therapeutic gastroscopes within its ELUXEO 8000 portfolio at Endocon 2026. Improved maneuverability and dedicated therapeutic channels support complex gastrointestinal procedures and compatible accessories. |
| October 2026 | Olympus Corporation | Olympus introduced CADDIE PLUS with real-time polyp size classification and withdrawal-time tracking capabilities. The platform supports endoscopic assessment and decision-making during colonoscopy procedures. |
Future Outlook
The Endoscopic Accessories Market is expected to experience sustained development as healthcare providers increasingly adopt minimally invasive diagnostic and therapeutic procedures. GI Endoscopy will remain an important application through demand for tissue sampling, polypectomy, hemostasis, and advanced lesion resection instruments. Manufacturers will continue improving accessory flexibility, deployment precision, and compatibility with modern endoscopic platforms. Single-use technologies and validated reprocessing requirements will influence product selection.
North America will remain an important center for advanced endoscopic treatment, while Europe and Asia-Pacific will contribute through technology innovation and expanding healthcare services. Companies including Olympus Corporation, Fujifilm Holdings Corporation, Stryker, Karl Storz, Hoya Group, Conmed, and other listed participants will continue developing specialized accessories and compatible procedural technologies. Future competitiveness will depend on device reliability, clinical usability, infection prevention, and manufacturing quality.
Endoscopic Accessories Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 2095.78 Million in 2026 |
|
|
Market Size Value By |
USD 3744.45 Million by 2035 |
|
|
Growth Rate |
CAGR of 6.66% from 2026-2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Endoscopic Accessories Market is expected to reach USD 3744.45 Million by 2035.
The Endoscopic Accessories Market is expected to exhibit a CAGR of 6.66% by 2035.
Olympus Corporation, Fujifilm Holdings Corporation, Stryker, Hoya Group, Karl Storz, Medovations, Endo-Technik, EndoChoice Holdings, US Endoscopy, Conmed, Solos Endoscopy, Medivators, Medorah Meditek
In 2026, the Endoscopic Accessories Market value will reach at USD 2095.78 Million.